Importance of education in managing type 2 diabetes during Ramadan.

نویسندگان

  • Doaa Farid
  • Ellen Rosenberg
  • Gillian Bartlett
چکیده

Approximately 50 million Muslim adults with type 1 diabetes (T1D) and type 2 diabetes (T2D) go without food or drink from sunrise to sunset during the month of Ramadan, despite having a religious exemption.1 For many Muslim people with diabetes, Ramadan is a religious conviction and the intermittent fasting is a key component of its observance. The EPIDIAR (Epidemiology of Diabetes and Ramadan) study investigated this phenomenon in 12 243 participants from 13 countries and observed that 43% of T1D patients and 79% of T2D patients fast during the month of Ramadan.2 Fasting during Ramadan potentially affects dietary habits, daily physical activity, sleeping patterns, glycemic control, weight, lipid profile, and food intake. Figure 1 shows a typical Ramadan day. The benefits and risks of intermittent fasting in people with T2D are still being explored. The latest findings suggest that fasting T2D patients might be at risk of hypoglycemia with inappropriate continuation of pharmacotherapies; patients with T1D have a 4.7-fold (0.14 vs 0.03 episodes per month) and patients with T2D have a 7.5-fold (0.03 vs 0.004 episodes per month) increased risk of severe hypoglycemia.1 Some other important potential complications of fasting for these patients are hyperglycemia, diabetic ketoacidosis, dehydration, and thrombosis. Vasan et al conducted a prospective assessment of dietary patterns in Muslim patients in Sweden with T2D who undertook fasting during Ramadan.3 Patients’ compliance with nutritional guidelines was poor, causing an increase in consumption of all dietary components (fat, carbohydrates, and proteins). The authors concluded that these patients needed close monitoring during fasting.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Report of the second conference on diabetes and Ramadan, Iran, Mashhad, 2017

The phrase " va man kan marizan " on the fasting of the holy month of Ramadan in the verse of 185 of the Qur'anic Surah, followed by the phrase "Yaridullah Bekem Alisar va Yerido bekom alosr", is undoubtedly a major task of medical scientific assemblies. To conduct comprehensive and evidence-based studies, firstly, should determine the course of fasting in patients, and, second, patients who ma...

متن کامل

Type 2 diabetes patient’s perspective on Ramadan fasting: a qualitative study

OBJECTIVE We evaluated the beliefs, experience and diabetes management strategies of type 2 diabetes mellitus (T2DM) Muslim patients that chose to fast during Ramadan. RESEARCH DESIGN AND METHODS A semistructured focus group interview was conducted with 53 participants with T2DM. Participants were purposefully sampled and asked to share their perspective on Ramadan fasting. All interviews wer...

متن کامل

Type 1 diabetes and Ramadan fasting: A narrative review

Ramadan fasting is an important pillars of Islam .although patients and children expected from fasting during Ramadan, but every diabetic adolescents intends to fast should consult his diabetes management time, and intensive monitoring of blood glucose and urine ketones .close observation by endocrinologist, and weekly follow- up and highly individualized planning for each diabetic person is es...

متن کامل

The Effect of Nutritional Education Program Based on Health Belief Model (HBM) on the Knowledge of Fasting Type 2 Diabetic Patients

Background and Objectives: Studies have shown that many people with diabetes are fasting in the holy month of Ramadan. Ramadan fasting causes several changes in metabolism, habit and lifestyle that are associated with an increased risk of hypoglycemia and hyperglycemia in diabetic patients. An educational program based on behavioral science theory in the field of diet and medication changes, pr...

متن کامل

Safety of sodium-glucose co-transporter 2 inhibitors during Ramadan fasting: Evidence, perceptions and guidelines

Sodium-glucose co-transporter 2 (SGLT2) inhibitors are a new glucose-lowering therapy for T2DM with documented benefits on blood glucose, hypertension, weight reduction and long term cardiovascular benefit. They have an inherent osmotic diuretic effect and lead to some volume loss and possible dehydration. There is some concern about the safety of using SGLT2 inhibitors in Muslim type 2 diabete...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Canadian family physician Medecin de famille canadien

دوره 60 6  شماره 

صفحات  -

تاریخ انتشار 2014